Vertex Pharmaceuticals
VRTX
#122
Rank
NZ$197.81 B
Marketcap
$766.42
Share price
-1.48%
Change (1 day)
29.05%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$1.50 B

According to Vertex Pharmaceuticals's latest financial reports the company's total debt is NZ$1.50 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Vertex Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$1.27 B-9.79%
2022-12-31NZ$1.41 B0.32%
2021-12-31NZ$1.41 B9.02%
2020-12-31NZ$1.29 B32.1%
2019-12-31NZ$0.98 B12.17%
2018-12-31NZ$0.87 B2.41%
2017-12-31NZ$0.85 B-29.65%
2016-12-31NZ$1.21 B0.43%
2015-12-31NZ$1.20 B14.93%
2014-12-31NZ$1.05 B70.49%
2013-12-31NZ$0.61 B-27.44%
2012-12-31NZ$0.85 B45.51%
2011-12-31NZ$0.58 B-16.4%
2010-12-31NZ$0.69 B227.54%
2009-12-31NZ$0.21 B-57.19%
2008-12-31NZ$0.49 B1825.68%
2007-12-31NZ$25.87 M-85.27%
2006-12-31NZ$0.17 B-33.33%
2005-12-31NZ$0.26 B-43.88%
2004-12-31NZ$0.46 B-8.48%
2003-12-31NZ$0.51 B-18.19%
2002-12-31NZ$0.62 B-20.53%
2001-12-31NZ$0.78 B-3.51%
2000-12-31NZ$0.81 B5953.27%
1999-12-31NZ$13.5 M-27.36%
1998-12-31NZ$18.59 M28.47%
1997-12-31NZ$14.47 M20.32%
1996-12-31NZ$12.03 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
NZ$37.74 B 2,401.61%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$114.17 B 7,467.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$61.07 B 3,948.43%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$87.29 B 5,685.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$67.06 B 4,345.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$81.73 M-94.58%๐Ÿ‡บ๐Ÿ‡ธ USA